Aust J Gen Pract
A new facial rash.
Sun C, Muir J
Read More
Source: PubMed
Ther Innov Regul Sci
Review of Drugs Approved via the 505(b)(2) Pathway: Uncovering Drug Development Trends and Regulatory Requirements.
Freije I, Lamouche S, Tanguay M
A 505(b)(2) application is a type of US new drug application (NDA) that contains full reports of investigations of safety and effectiveness, but where ...
Read More
Source: PubMed
Ther Innov Regul Sci
Updating the Clinical Picture of Facioscapulohumeral Muscular Dystrophy: Ramifications for Drug Development With Potential Solutions.
Huml RA, Uspenskaya-Cadoz O, Dawson J, Slifer Z
Facioscapulohumeral muscular dystrophy (FSHD) is a complex, inheritable, and rare muscle disease that affects the entire body. The major symptom of FS ...
Read More
Source: PubMed
Eat Weight Disord 2020 Feb 01
Eating self-efficacy: validation of a new brief scale.
Lombardo C, Cerolini S, Alivernini F, Ballesio A, Violani C, Fernandes M, Lucidi F
Eating self-efficacy (ESE) is the belief in one's ability to self-regulate eating. Social and emotional situations may be differently challenging depe ...
Read More
Source: PubMed
J Exp Orthop
There is poor accuracy in documenting the location of labral and chondral lesions observed during hip arthroscopy.
Hariri S, Sochacki KR, Harris AS, Safran MR
To determine and compare the accuracy and interobserver reliability of the different methods for localizing acetabular labral, acetabular chondral, an ...
Read More
Source: PubMed
